← Leaderboards
James Daniel Moody
Brigham Young University
$1,170,257
Attributed
$1,170,257
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $429.1K · FY2022–25$500K$375K$250K$125K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$1,170,257 · 2
By mechanism
R35$650,646 · 1
R15$519,611 · 1
Top collaborators
No co-investigators on record.
Most similar at Brigham Young University
Same institution · by research overlap
- Barry M Willardson$7,906,543
- Barry R Bickmore$781,427
- John M Chaston$467,333
- Eric H Christiansen$260,368
- Joshua Lyon Andersen$2,244,661
Others in their field
Other Rising Stars on “United States National Institutes Of Health”
- Gary Mays · Axle Informatics, Llc$64,794,917
- Mari Ostendorf · University Of Washington$51,931,230
- Nancy Jean Sullivan · Boston University Medical Campus$42,041,758
- Jeffrey Leintz · National Opinion Research Center$40,628,545
- Brian Zavertnik · Palantir Technologies, Inc.$33,059,912
- Joan Grand · Mitre Corporation$32,826,287
Research focus
United States National Institutes Of HealthSymptom ManagementProteinsProgramsResolutionStructureMissionInterestMolecular DiseasePolymersPublic HealthCostResourcesCrystallizationCrystallographyHealth Care CostsBiotechnologyHuman DiseaseMolecular ChaperonesEffective TherapyNational Institute Of General Medical SciencesNew TechnologyProtein StructureAcceleration
Grant awards (4)
Expanding the capabilities and usage of the TELSAM protein crystallization chaperone$371,798
R35 · FY2025 · GM · contact PI
Expanding the capabilities and usage of the TELSAM protein crystallization chaperone$278,848
R35 · FY2024 · GM · contact PI
TELSAM polymers are powerful crystallization chaperones meriting continued investigation (Diversity Supplement)$90,516
R15 · FY2024 · GM · contact PI
TELSAM polymers are powerful crystallization chaperones meriting continued investigation$429,095
R15 · FY2022 · GM · contact PI